News & Updates
Filter by Specialty:
Adjuvant pembrolizumab holds promise in bladder cancer
28 Feb 2024
byAudrey Abella
The phase III AMBASSADOR Alliance A031501 trial showed a statistically significant and clinically meaningful improvement in disease-free survival (DFS) with adjuvant pembrolizumab compared with observation in patients with high-risk locally advanced muscle-invasive urothelial carcinoma (MIUC) after radical surgery regardless of PD-L1 status.